Cleared Traditional

K984545 - RELEASE 2 OF PHILIPS INTEGRIS SERIES (V5000, BV5000, H5000, BH5000, HM2000) SYSTEMS

K984545 is an FDA 510(k) clearance for RELEASE 2 OF PHILIPS INTEGRIS SERIES (V5000, manufactured by Philips Medical Systems North America, Inc.. The device is a Class 2 Radiology device with product code IZI cleared through the Traditional 510(k) pathway after a 65-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1999
Decision
65d
Days
Class 2
Risk

K984545 is an FDA 510(k) clearance for the RELEASE 2 OF PHILIPS INTEGRIS SERIES (V5000, BV5000, H5000, BH5000, HM2000) S.... Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Philips Medical Systems North America, Inc. (Da Best, NL). The FDA issued a Cleared decision on February 25, 1999 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Philips Medical Systems North America, Inc. devices

FDA 510(k) Submission Details - K984545

510(k) Number K984545 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 1998
Decision Date February 25, 1999
Days to Decision 65 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 107d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IZI Device Classification - Class 2, Special Controls

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 161
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K984545.
QUANTITATIVE ANALYSIS OF LEFT VENTRICULAR ANGIOGRAMS (QLV)
K993765 · Medis Medical Imaging Systems BV · Nov 1999
DIGITAL IMAGING SYSTEM (BSR)
K991922 · Siemens Medical Solutions USA, Inc. · Sep 1999
HITACHI VERSIFLEX
K991231 · Hitachi Medical Systems America, Inc. · May 1999
PHILIPS INTEGRIS 3D RA OPTION
K983877 · Philips Medical Systems North America, Inc. · Dec 1998
CAAS II LVA BIPLANE OPTION
K982203 · Pie Medical Equipment B.V. · Jul 1998
THE TCS-MEDCON'S TELECARDIOLOGY SYSTEM
K974679 · Medcon , Ltd. · Mar 1998